Filing Details
- Accession Number:
- 0001209191-12-041040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-08 21:48:13
- Reporting Period:
- 2012-08-06
- Filing Date:
- 2012-08-08
- Accepted Time:
- 2012-08-08 21:48:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397266 | K Matthew Fust | C/O Onyx Pharmaceuticals, Inc. 249 East Grand Ave. South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-06 | 17,492 | $34.48 | 85,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-06 | 15,000 | $71.74 | 70,416 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-08-06 | 6,636 | $71.63 | 63,780 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-08-06 | 373 | $71.93 | 63,407 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-08-06 | 17,492 | $0.00 | 17,492 | $34.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 72,008 | 2019-01-04 | No | 4 | M | Direct |
Footnotes
- The shares were sold at prices between $71.64 and $71.889. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $71.56 and $71.64. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Twenty-Five percent of the shares subject to the option vest and become exercisable one year from the date of grant and vest and become exercisable at a rate of 1/48th per month thereafter.
Billionaire Hedge Funds
